Automatic Immunohematology Analyzer
Automatic Immunohematology Analyzer market is segmented by region (country), players, by Type and ... Read More
Global and United States Biosimilars/Follow-on-Biologics Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Biosimilars/Follow-on-Biologics Product Introduction
1.2 Global Biosimilars/Follow-on-Biologics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biosimilars/Follow-on-Biologics Sales in US$ Million for the Year 2017-2028
1.2.2 Global Biosimilars/Follow-on-Biologics Sales in Volume for the Year 2017-2028
1.3 United States Biosimilars/Follow-on-Biologics Outlook 2017 VS 2022 VS 2028
1.3.1 United States Biosimilars/Follow-on-Biologics Sales in US$ Million for the Year 2017-2028
1.3.2 United States Biosimilars/Follow-on-Biologics Sales in Volume for the Year 2017-2028
1.4 Biosimilars/Follow-on-Biologics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Biosimilars/Follow-on-Biologics in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Biosimilars/Follow-on-Biologics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Biosimilars/Follow-on-Biologics Market Dynamics
1.5.1 Biosimilars/Follow-on-Biologics Industry Trends
1.5.2 Biosimilars/Follow-on-Biologics Market Drivers
1.5.3 Biosimilars/Follow-on-Biologics Market Challenges
1.5.4 Biosimilars/Follow-on-Biologics Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Biosimilars/Follow-on-Biologics Market Segment by Type
2.1.1 Human Growth Hormone
2.1.2 Erythropoietin
2.1.3 Monoclonal Antibodies
2.1.4 Insulin
2.1.5 Interferon
2.1.6 Granulocyte-Colony Stimulating Factor
2.1.7 Peptide
2.1.8 Others
2.2 Global Biosimilars/Follow-on-Biologics Market Size by Type
2.2.1 Global Biosimilars/Follow-on-Biologics Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Biosimilars/Follow-on-Biologics Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Biosimilars/Follow-on-Biologics Market Size by Type
2.3.1 United States Biosimilars/Follow-on-Biologics Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Biosimilars/Follow-on-Biologics Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Biosimilars/Follow-on-Biologics Market Segment by Application
3.1.1 Blood Disorders
3.1.2 Oncology Diseases
3.1.3 Chronic and Autoimmune Diseases
3.1.4 Growth Hormone Deficiencies
3.1.5 Others
3.2 Global Biosimilars/Follow-on-Biologics Market Size by Application
3.2.1 Global Biosimilars/Follow-on-Biologics Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Biosimilars/Follow-on-Biologics Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Biosimilars/Follow-on-Biologics Market Size by Application
3.3.1 United States Biosimilars/Follow-on-Biologics Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Biosimilars/Follow-on-Biologics Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Biosimilars/Follow-on-Biologics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Biosimilars/Follow-on-Biologics Competitor Landscape by Company
4.1 Global Biosimilars/Follow-on-Biologics Market Size by Company
4.1.1 Top Global Biosimilars/Follow-on-Biologics Manufacturers Ranked by Revenue (2021)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Manufacturer (2017-2022)
4.1.3 Global Biosimilars/Follow-on-Biologics Sales by Manufacturer (2017-2022)
4.1.4 Global Biosimilars/Follow-on-Biologics Price by Manufacturer (2017-2022)
4.2 Global Biosimilars/Follow-on-Biologics Concentration Ratio (CR)
4.2.1 Biosimilars/Follow-on-Biologics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Biosimilars/Follow-on-Biologics in 2021
4.2.3 Global Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution, Product Type
4.3.1 Global Biosimilars/Follow-on-Biologics Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Biosimilars/Follow-on-Biologics Product Type
4.3.3 Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Biosimilars/Follow-on-Biologics Market Size by Company
4.5.1 Top Biosimilars/Follow-on-Biologics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biosimilars/Follow-on-Biologics Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Biosimilars/Follow-on-Biologics Sales by Players (2020, 2021 & 2022)
5 Global Biosimilars/Follow-on-Biologics Market Size by Region
5.1 Global Biosimilars/Follow-on-Biologics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biosimilars/Follow-on-Biologics Market Size in Volume by Region (2017-2028)
5.2.1 Global Biosimilars/Follow-on-Biologics Sales in Volume by Region: 2017-2022
5.2.2 Global Biosimilars/Follow-on-Biologics Sales in Volume Forecast by Region (2023-2028)
5.3 Global Biosimilars/Follow-on-Biologics Market Size in Value by Region (2017-2028)
5.3.1 Global Biosimilars/Follow-on-Biologics Sales in Value by Region: 2017-2022
5.3.2 Global Biosimilars/Follow-on-Biologics Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biosimilars/Follow-on-Biologics Market Size YoY Growth 2017-2028
6.1.2 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biosimilars/Follow-on-Biologics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Biosimilars/Follow-on-Biologics Market Size YoY Growth 2017-2028
6.3.2 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biosimilars/Follow-on-Biologics Market Size YoY Growth 2017-2028
6.4.2 Latin America Biosimilars/Follow-on-Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biosimilars/Follow-on-Biologics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis Biosimilars/Follow-on-Biologics Products Offered
7.1.5 Novartis Recent Development
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Corporation Information
7.2.2 Synthon Pharmaceuticals Description and Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Products Offered
7.2.5 Synthon Pharmaceuticals Recent Development
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporation Information
7.3.2 Teva Pharmaceutical Industries Description and Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Products Offered
7.3.5 Teva Pharmaceutical Industries Recent Development
7.4 LG Life Sciences
7.4.1 LG Life Sciences Corporation Information
7.4.2 LG Life Sciences Description and Business Overview
7.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Products Offered
7.4.5 LG Life Sciences Recent Development
7.5 Celltrion
7.5.1 Celltrion Corporation Information
7.5.2 Celltrion Description and Business Overview
7.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Celltrion Biosimilars/Follow-on-Biologics Products Offered
7.5.5 Celltrion Recent Development
7.6 Biocon
7.6.1 Biocon Corporation Information
7.6.2 Biocon Description and Business Overview
7.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Biocon Biosimilars/Follow-on-Biologics Products Offered
7.6.5 Biocon Recent Development
7.7 Hospira
7.7.1 Hospira Corporation Information
7.7.2 Hospira Description and Business Overview
7.7.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Hospira Biosimilars/Follow-on-Biologics Products Offered
7.7.5 Hospira Recent Development
7.8 Merck Group
7.8.1 Merck Group Corporation Information
7.8.2 Merck Group Description and Business Overview
7.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck Group Biosimilars/Follow-on-Biologics Products Offered
7.8.5 Merck Group Recent Development
7.9 Biogen idec, Inc.
7.9.1 Biogen idec, Inc. Corporation Information
7.9.2 Biogen idec, Inc. Description and Business Overview
7.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Products Offered
7.9.5 Biogen idec, Inc. Recent Development
7.10 Genentech (Roche Group)
7.10.1 Genentech (Roche Group) Corporation Information
7.10.2 Genentech (Roche Group) Description and Business Overview
7.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Products Offered
7.10.5 Genentech (Roche Group) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Biosimilars/Follow-on-Biologics Industry Chain Analysis
8.2 Biosimilars/Follow-on-Biologics Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Biosimilars/Follow-on-Biologics Distributors
8.3 Biosimilars/Follow-on-Biologics Production Mode & Process
8.4 Biosimilars/Follow-on-Biologics Sales and Marketing
8.4.1 Biosimilars/Follow-on-Biologics Sales Channels
8.4.2 Biosimilars/Follow-on-Biologics Distributors
8.5 Biosimilars/Follow-on-Biologics Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Biosimilars/Follow-on-Biologics CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Biosimilars/Follow-on-Biologics Market Trends
Table 3. Biosimilars/Follow-on-Biologics Market Drivers
Table 4. Biosimilars/Follow-on-Biologics Market Challenges
Table 5. Biosimilars/Follow-on-Biologics Market Restraints
Table 6. Global Biosimilars/Follow-on-Biologics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Biosimilars/Follow-on-Biologics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Biosimilars/Follow-on-Biologics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Biosimilars/Follow-on-Biologics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Biosimilars/Follow-on-Biologics Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Biosimilars/Follow-on-Biologics Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Biosimilars/Follow-on-Biologics Revenue Share by Manufacturer, 2017-2022
Table 13. Global Biosimilars/Follow-on-Biologics Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Biosimilars/Follow-on-Biologics Sales Share by Manufacturer, 2017-2022
Table 15. Global Biosimilars/Follow-on-Biologics Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Biosimilars/Follow-on-Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Biosimilars/Follow-on-Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars/Follow-on-Biologics as of 2021)
Table 18. Top Players of Biosimilars/Follow-on-Biologics in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Biosimilars/Follow-on-Biologics Product Type
Table 20. Date of International Manufacturers Enter into Biosimilars/Follow-on-Biologics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Biosimilars/Follow-on-Biologics Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Biosimilars/Follow-on-Biologics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Biosimilars/Follow-on-Biologics Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Biosimilars/Follow-on-Biologics Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Biosimilars/Follow-on-Biologics Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Biosimilars/Follow-on-Biologics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Biosimilars/Follow-on-Biologics Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Biosimilars/Follow-on-Biologics Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Biosimilars/Follow-on-Biologics Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Biosimilars/Follow-on-Biologics Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Biosimilars/Follow-on-Biologics Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Biosimilars/Follow-on-Biologics Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Biosimilars/Follow-on-Biologics Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Biosimilars/Follow-on-Biologics Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Biosimilars/Follow-on-Biologics Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Biosimilars/Follow-on-Biologics Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Novartis Biosimilars/Follow-on-Biologics Product
Table 46. Novartis Recent Development
Table 47. Synthon Pharmaceuticals Corporation Information
Table 48. Synthon Pharmaceuticals Description and Business Overview
Table 49. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Synthon Pharmaceuticals Product
Table 51. Synthon Pharmaceuticals Recent Development
Table 52. Teva Pharmaceutical Industries Corporation Information
Table 53. Teva Pharmaceutical Industries Description and Business Overview
Table 54. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Teva Pharmaceutical Industries Product
Table 56. Teva Pharmaceutical Industries Recent Development
Table 57. LG Life Sciences Corporation Information
Table 58. LG Life Sciences Description and Business Overview
Table 59. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. LG Life Sciences Product
Table 61. LG Life Sciences Recent Development
Table 62. Celltrion Corporation Information
Table 63. Celltrion Description and Business Overview
Table 64. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Celltrion Product
Table 66. Celltrion Recent Development
Table 67. Biocon Corporation Information
Table 68. Biocon Description and Business Overview
Table 69. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Biocon Product
Table 71. Biocon Recent Development
Table 72. Hospira Corporation Information
Table 73. Hospira Description and Business Overview
Table 74. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Hospira Product
Table 76. Hospira Recent Development
Table 77. Merck Group Corporation Information
Table 78. Merck Group Description and Business Overview
Table 79. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Merck Group Product
Table 81. Merck Group Recent Development
Table 82. Biogen idec, Inc. Corporation Information
Table 83. Biogen idec, Inc. Description and Business Overview
Table 84. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Biogen idec, Inc. Product
Table 86. Biogen idec, Inc. Recent Development
Table 87. Genentech (Roche Group) Corporation Information
Table 88. Genentech (Roche Group) Description and Business Overview
Table 89. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Genentech (Roche Group) Product
Table 91. Genentech (Roche Group) Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Biosimilars/Follow-on-Biologics Customers List
Table 95. Biosimilars/Follow-on-Biologics Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars/Follow-on-Biologics Product Picture
Figure 2. Global Biosimilars/Follow-on-Biologics Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Biosimilars/Follow-on-Biologics Market Size 2017-2028 (US$ Million)
Figure 4. Global Biosimilars/Follow-on-Biologics Sales 2017-2028 (K Pcs)
Figure 5. United States Biosimilars/Follow-on-Biologics Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Biosimilars/Follow-on-Biologics Market Size 2017-2028 (US$ Million)
Figure 7. United States Biosimilars/Follow-on-Biologics Sales 2017-2028 (K Pcs)
Figure 8. United States Biosimilars/Follow-on-Biologics Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Biosimilars/Follow-on-Biologics Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Biosimilars/Follow-on-Biologics Report Years Considered
Figure 11. Product Picture of Human Growth Hormone
Figure 12. Product Picture of Erythropoietin
Figure 13. Product Picture of Monoclonal Antibodies
Figure 14. Product Picture of Insulin
Figure 15. Product Picture of Interferon
Figure 16. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 17. Product Picture of Peptide
Figure 18. Product Picture of Others
Figure 19. Global Biosimilars/Follow-on-Biologics Market Share by Type in 2022 & 2028
Figure 20. Global Biosimilars/Follow-on-Biologics Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. Global Biosimilars/Follow-on-Biologics Sales Market Share in Value by Type (2017-2028)
Figure 22. Global Biosimilars/Follow-on-Biologics Sales by Type (2017-2028) & (K Pcs)
Figure 23. Global Biosimilars/Follow-on-Biologics Sales Market Share in Volume by Type (2017-2028)
Figure 24. Global Biosimilars/Follow-on-Biologics Price by Type (2017-2028) & (USD/Pcs)
Figure 25. United States Biosimilars/Follow-on-Biologics Market Share by Type in 2022 & 2028
Figure 26. United States Biosimilars/Follow-on-Biologics Sales in Value by Type (2017-2028) & (US$ Million)
Figure 27. United States Biosimilars/Follow-on-Biologics Sales Market Share in Value by Type (2017-2028)
Figure 28. United States Biosimilars/Follow-on-Biologics Sales by Type (2017-2028) & (K Pcs)
Figure 29. United States Biosimilars/Follow-on-Biologics Sales Market Share in Volume by Type (2017-2028)
Figure 30. United States Biosimilars/Follow-on-Biologics Price by Type (2017-2028) & (USD/Pcs)
Figure 31. Product Picture of Blood Disorders
Figure 32. Product Picture of Oncology Diseases
Figure 33. Product Picture of Chronic and Autoimmune Diseases
Figure 34. Product Picture of Growth Hormone Deficiencies
Figure 35. Product Picture of Others
Figure 36. Global Biosimilars/Follow-on-Biologics Market Share by Application in 2022 & 2028
Figure 37. Global Biosimilars/Follow-on-Biologics Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. Global Biosimilars/Follow-on-Biologics Sales Market Share in Value by Application (2017-2028)
Figure 39. Global Biosimilars/Follow-on-Biologics Sales by Application (2017-2028) & (K Pcs)
Figure 40. Global Biosimilars/Follow-on-Biologics Sales Market Share in Volume by Application (2017-2028)
Figure 41. Global Biosimilars/Follow-on-Biologics Price by Application (2017-2028) & (USD/Pcs)
Figure 42. United States Biosimilars/Follow-on-Biologics Market Share by Application in 2022 & 2028
Figure 43. United States Biosimilars/Follow-on-Biologics Sales in Value by Application (2017-2028) & (US$ Million)
Figure 44. United States Biosimilars/Follow-on-Biologics Sales Market Share in Value by Application (2017-2028)
Figure 45. United States Biosimilars/Follow-on-Biologics Sales by Application (2017-2028) & (K Pcs)
Figure 46. United States Biosimilars/Follow-on-Biologics Sales Market Share in Volume by Application (2017-2028)
Figure 47. United States Biosimilars/Follow-on-Biologics Price by Application (2017-2028) & (USD/Pcs)
Figure 48. North America Biosimilars/Follow-on-Biologics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 49. North America Biosimilars/Follow-on-Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. U.S. Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Canada Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Europe Biosimilars/Follow-on-Biologics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 53. Europe Biosimilars/Follow-on-Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. Germany Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. France Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. U.K. Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Italy Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Russia Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Asia-Pacific Biosimilars/Follow-on-Biologics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 60. Asia-Pacific Biosimilars/Follow-on-Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 61. China Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Japan Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. South Korea Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. India Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Australia Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. China Taiwan Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Indonesia Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Thailand Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Malaysia Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Latin America Biosimilars/Follow-on-Biologics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 71. Latin America Biosimilars/Follow-on-Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Mexico Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Brazil Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Argentina Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Middle East & Africa Biosimilars/Follow-on-Biologics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 76. Middle East & Africa Biosimilars/Follow-on-Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 77. Turkey Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Saudi Arabia Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. UAE Biosimilars/Follow-on-Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 80. Biosimilars/Follow-on-Biologics Value Chain
Figure 81. Biosimilars/Follow-on-Biologics Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Group Biogen idec, Inc. Genentech (Roche Group)